These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8380213)

  • 21. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice.
    Scherrer G; Befort K; Contet C; Becker J; Matifas A; Kieffer BL
    Eur J Neurosci; 2004 Apr; 19(8):2239-48. PubMed ID: 15090050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphine-induced antinociception and reward in "humanized" mice expressing the mu opioid receptor A118G polymorphism.
    Henderson-Redmond AN; Yuill MB; Lowe TE; Kline AM; Zee ML; Guindon J; Morgan DJ
    Brain Res Bull; 2016 May; 123():5-12. PubMed ID: 26521067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antinociceptive properties of Micrurus lemniscatus venom.
    Leite dos Santos GG; Casais e Silva LL; Pereira Soares MB; Villarreal CF
    Toxicon; 2012 Nov; 60(6):1005-12. PubMed ID: 22841808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors.
    Pacheco Dda F; Romero TR; Duarte ID
    Brain Res; 2014 May; 1562():69-75. PubMed ID: 24675031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
    Tershner SA; Helmstetter FJ
    Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mu and delta opioid receptor knockout mice show increased colonic sensitivity.
    Reiss D; Ceredig RA; Secher T; Boué J; Barreau F; Dietrich G; Gavériaux-Ruff C
    Eur J Pain; 2017 Apr; 21(4):623-634. PubMed ID: 27748566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
    Raffa RB; Friderichs E; Reimann W; Shank RP; Codd EE; Vaught JL
    J Pharmacol Exp Ther; 1992 Jan; 260(1):275-85. PubMed ID: 1309873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.
    Tseng LF; Narita M; Suganuma C; Mizoguchi H; Ohsawa M; Nagase H; Kampine JP
    J Pharmacol Exp Ther; 2000 Feb; 292(2):576-83. PubMed ID: 10640294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice.
    Hosohata Y; Vanderah TW; Burkey TH; Ossipov MH; Kovelowski CJ; Sora I; Uhl GR; Zhang X; Rice KC; Roeske WR; Hruby VJ; Yamamura HI; Lai J; Porreca F
    Eur J Pharmacol; 2000 Feb; 388(3):241-8. PubMed ID: 10675732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception.
    Hutcheson DM; Sánchez-Blazquez P; Rodriguez-Diaz M; Garzon J; Schmidhammer H; Borsodi A; Roques BP; Maldonado R
    Eur J Pharmacol; 1999 Oct; 383(1):29-37. PubMed ID: 10556678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
    Noble F; Blommaert A; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1995 Jan; 273(1-2):145-51. PubMed ID: 7737308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xylazine induced central antinociception mediated by endogenous opioids and μ-opioid receptor, but not δ-or κ-opioid receptors.
    Romero TR; Pacheco Dda F; Duarte ID
    Brain Res; 2013 Apr; 1506():58-63. PubMed ID: 23485547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
    Bhargava HN; Cao YJ; Zhao GM
    Brain Res; 1997 Mar; 752(1-2):234-8. PubMed ID: 9106462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
    Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
    Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice.
    Li SR; Wang T; Wang R; Dai X; Chen Q; Li RD
    Brain Res; 2005 May; 1043(1-2):132-8. PubMed ID: 15862526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception.
    Campbell VC; Taylor RE; Tizabi Y
    Alcohol Clin Exp Res; 2007 Aug; 31(8):1435-40. PubMed ID: 17550364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.